Please login to the form below

Not currently logged in
Email:
Password:

Chugai

This page shows the latest Chugai news and features for those working in and with pharma, biotech and healthcare.

Roche’s Soliris rival Enspryng bags FDA approval

Roche’s Soliris rival Enspryng bags FDA approval

The new NMOSD treatment was originally designed by Roche’s Japanese subsidiary Chugai, using novel recycling antibody technology.

Latest news

More from news
Approximately 6 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Insights from Cannes Lions Health Festival 2018 Insights from Cannes Lions Health Festival 2018

    Case Study: Ouchie . Agency: Havas Lynx. Client: Chugai/Roche. Award: Silver Lion.

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

  • Deal Watch May 2016 Deal Watch May 2016

    In the ever popular oncology field, Chugai has signed up with Osaka University for a multiyear investment worth $91.1m to focus on the development of treatments for cancer and the

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    225. Athersys / Chugai. Licence and collaboration Japan. Phase 2 stem cell therapy for treatment of ischaemic stroke.

  • Pharma deals during August 2014 Pharma deals during August 2014

    Rumours of a $10bn Chugai bid have swirled for weeks but to no avail. ... This is Roche's largest acquisition since 2009 when the remaining stake in Genentech was acquired and may well have put paid to plans to fully acquire Chugai.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...